A cross-sectional study of inflammatory markers as determinants of circulating kynurenines in the Lung Cancer Cohort Consortium

Grants

Funding Acknowledgements

The Lung Cancer Cohort Consortium (LC3) was supported by the National Institutes of Health/National Cancer Institute (grant numbers 1U1CA155340 and U19 CA203654) and National Health and Medical Research Council (NHMRC) (Grant ID: 1050198).We thank all cohorts and all cohort participants for making this research possible. MCCS cohort recruitment was funded by VicHealth and Cancer Council Victoria. The MCCS was further augmented by Australian National Health and Medical Research Council grants 209057, 396414 and 1074383 and by infrastructure provided by Cancer Council Victoria. Cases and their vital status were ascertained through the Victorian Cancer Registry and the Australian Institute of Health and Welfare, including the National Death Index and the Australian Cancer Database (ACD). New South Wales (NSW) cancer registry data were obtained via the ACD with the assistance of the NSW Ministry of Health.The WHI program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services through contracts HHSN268201600018C, HHSN268201600001C, HHSN268201600002C, HHSN268201600003C, and HHSN268201600004C. The WHI authors thank the WHI investigators and staff for their dedication, and the study participants for making the program possible. The Health Professionals Follow-up Study (HPFS) and Nurses' Health Study (NHS) thank the cohort participants and staff for their valuable contributions as well as the following state cancer registries for their help: AL, AZ, AR, CA, CO, CT, DE, FL, GA, ID, IL, IN, IA, KY, LA, ME, MD, MA, MI, NE, NH, NJ, NY, NC, ND, OH, OK, OR, PA, RI, SC, TN, TX, VA, WA, WY. The HPFS and NHS were supported by the NCI at the NIH (grant numbers UM1 CA186107, P50 CA127003, P01 CA87969, and U01 CA167552). The Multiethnic Cohort Study cohort acknowledges partial funding from National Institutes of Health grant U01 CA164973. Cancer incidence data for the CLUE cohort were provided by the Maryland Cancer Registry, Center for Cancer Prevention and Control, Maryland Department of Health, with funding from the State of Maryland and the Maryland Cigarette Restitution Fund. The collection and availability of cancer registry data is also supported by the Cooperative Agreement NU58DP006333, funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services. The ATBC Study is supported by the Intramural Research Program of the U.S. National Cancer Institute, National Institutes of Health, Department of Health and Human Services.The NYUWHS is supported by grants U01 CA182934 and P30 CA16087 from the National Cancer Institute and by grant P30 ES000260 from the National Institute of Environmental Health Sciences. Funding for the PHS is through grants CA097193, CA34944, CA40360, HL26490, and HL34595 from the National Institutes of Health, Bethesda, MD. The Singapore Chinese Health Study and the Shanghai Cohort Study acknowledge partial funding National Institutes of Health grants R01CA144034 and UM1CA182876. The Shanghai Women's Health Study (UM1 CA182910), Shanghai Men's Health Study (UM1 CA173640), and Southern Community Cohort Study (U01 CA202979) were supported by grants from US National Cancer Institute. Acknowledgement for HUNT: The Trondelag Health Study (HUNT) is a collaboration between HUNT Research Centre (Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology NTNU), Trondelag County Council, Central Norway Regional Health Authority, and the Norwegian Institute of Public Health. The Southern Community Cohort Study is supported by grant U01CA202979 from the National Cancer Institute.